Salesforce.com to B...
Health Care: Drugs
GTx Inc. (GTXI: NASDAQ)
$2.71 -0.08 | -2.87%
06/04/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 75.30 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | n.a. | 12.50 |
| Beta | 0.98 | 0.58 | 0.98 |
| Price to Sales (TTM) | 24.09 | 4.62 | 1.42 |
| Price to Book (MRQ) | 2.84 | 3.44 | 2.41 |
| Price to Tangible Book (MRQ) | 2.85 | 6.74 | 5.08 |
| Price to Cash Flow (TTM) | -4.30 | 26.10 | 9.80 |
| Price to Free Cash Flow (TTM) | -5.10 | 48.80 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.50 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.20 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | n.a. | -0.76 |
| Payout Ratio (TTM) | 0.00 | 3.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | -80.30 | 9.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -75.70 | 7.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 22.65 | 9.03 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | -46.89 | -4.13 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 11.00 | 2.90 | 1.10 |
| Current Ratio (MRQ) | 11.90 | 3.50 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.41 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.45 | 0.96 |
| Interest Coverage (TTM) | n.a. | 6.20 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 97.40 | 84.10 | 46.90 |
| Gross Margin - 5 Yr Avg | 97.00 | 83.50 | 47.70 |
| EBITD Margin (TTM) | n.a. | 27.30 | 18.90 |
| EBITD - 5 Yr Avg | -230.51 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | n.a. | 14.10 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | n.a. | 10.60 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -5.74 | 0.10 | 0.09 |
| Net Profit Margin - 5 Yr Avg | n.a. | 5.30 | 7.00 |
| Return on Assets (TTM) | -61.80 | 4.70 | 3.10 |
| Return on Assets - 5 Yr Avg | -33.40 | 2.20 | 2.50 |
| Return on Investment (TTM) | -67.00 | 6.10 | 7.90 |
| Return on Investment - 5 Yr Avg | -69.30 | 2.80 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 80,811.00 | 701,747.00 | 449,376.00 |
| Net Income/Employee (TTM) | -464,211.00 | 83,589.00 | 39,003.00 |
| Receivable Turnover (TTM) | 9.10 | 5.80 | 7.60 |
| Inventory Turnover (TTM) | 1.20 | 1.30 | 8.30 |
| Asset Turnover (TTM) | 0.10 | 0.40 | 0.40 |
Portfolios with GTXI
- Portfolio NameUser Type
- UserCURRENT#1
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorHot Biotech Trades for Seco...
- ContributorStocks With Big Insider Buy...
- Contributor10 Cheap Biotech Stocks Tha...
- UserRimp's Stockpicks
- UserOwn
- ContributorUnder $5 Stocks That May Be...
- ContributorBarron's Insider Purchases ...
Latest GTXI Headlines from TheStreet
- 7 Stocks Soaring in a Weak Market 05.08.12 | 02:05 pm
- 5 Stocks Insiders Love Right Now 03.15.12 | 01:03 pm
- Insiders Trading AMAG, CLWR, GTXI 03.06.12 | 10:03 am
- GTx Stock Gaps Down On Today's Open (GTXI) 02.21.12 | 08:02 am
- 5 Stocks With Big Insider Buying 07.01.11 | 02:07 pm
- Insiders Trading KIOR, NWN, GTXI 06.29.11 | 10:06 am
- 10 Cheap Biotech Stocks That Could Soar 06.28.11 | 07:06 am
- GTx Inc. Stock Downgraded (GTXI) 05.11.11 | 06:05 am
- GTx Inc. Stock Upgraded (GTXI) 05.09.11 | 08:05 am
- Under $5 Stocks That May Be Headed Lower 08.09.10 | 06:08 am
Press Releases for GTXI
- GTx Announces Webcast Of Corporate Presentation At Jefferies 2012 Global Healthcare Conference - Business Wire 05.29.12 | 07:05 am
- GTx Announces Removal Of Full Clinical Hold By FDA For Capesaris® In Advanced Prostate Cancer - Business Wire 05.08.12 | 06:05 am
- GTx, Inc. To Host First Quarter 2012 Financial Results Conference Call And Webcast - Business Wire 04.25.12 | 07:04 am
- GTx Submits Clinical Hold Complete Response Letter To FDA For Its Planned Phase II Clinical Study Of Capesaris® For Secondary Hormonal Therapy Of Advanced Prostate Cancer - Business Wire 04.04.12 | 06:04 am
- GTx Announces Webcast Of Corporate Presentation At The Cowen And Co. Annual Health Care Conference - Business Wire 03.02.12 | 07:03 am
- GTx Announces Webcast Of Corporate Presentation At The Citi 2012 Global Health Care Conference - Business Wire 02.24.12 | 07:02 am
- GTx Provides Corporate Update And Reports 2011 Financial Results - Business Wire 02.21.12 | 06:02 am
- GTx Announces Clinical Hold On Clinical Trials Evaluating Capesaris® For First And Second Line Treatments Of Advanced Prostate Cancer - Business Wire 02.21.12 | 06:02 am
- GTx, Inc. To Host Fourth Quarter And Full Year 2011 Financial Results Conference Call And Webcast - Business Wire 02.13.12 | 07:02 am
- GTx Announces Webcast Of Corporate Presentation At The Lazard Capital Markets Annual Healthcare Conference - Business Wire 11.10.11 | 07:11 am
Partner Headlines for GTXI
- Analyzing GTx, Inc.'s Vast Upside Potential - Seeking Alpha 03.26.12 | 09:03 am
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Calls Purchased on GTx, Inc. - Benzinga 06.20.11 | 01:06 pm
- 7 Small-Cap Biotechs With Bullish Insider Buying in 2011 - Seeking Alpha 06.12.11 | 05:06 am
- 6 Stocks With New Uptrends - Seeking Alpha 05.26.11 | 07:05 am
- Company News for April 14, 2011 - Corporate Summary - Zacks 04.14.11 | 10:04 am
- GTx Up Nearly 26% (GTXI) - Benzinga 04.13.11 | 09:04 am
- 20 Stocks Under $3 With Significant Insider Buying - Seeking Alpha 03.14.11 | 09:03 am
- Insider Buys and Sells: Coca-Cola, Amazon - Seeking Alpha 11.09.10 | 09:11 am
- GTx Inc. Pops on Study Results (GTXI) - Benzinga 09.15.10 | 09:09 am
